# Lars Køber

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-k-ber/

## Facts

| Field | Value |
| --- | --- |
| Citations | 146,458 |
| Field | Heart Failure Treatment and Management |
| h-index | 156 |
| i10-index | 1,083 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5033436516 |
| ORCID iD | 0000-0002-6635-1466 |
| Works | 2,108 |

## Researcher papers

Showing 12 of 47.

- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest](https://scholariq.org/papers/targeted-temperature-management-at-33-c-versus-36-c-after-cardiac-arrest/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-4/)
- [2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2024 ESC Guidelines for the management of chronic coronary syndromes](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-chronic-coronary-syndromes/)
- [Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both](https://scholariq.org/papers/valsartan-captopril-or-both-in-myocardial-infarction-complicated-by-heart/)
- [Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome](https://scholariq.org/papers/lixisenatide-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome/)
- [2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2023-focused-update-of-the-2021-esc-guidelines-for-the-diagnosis-and-treatment/)
- [2024 ESC Guidelines for the management of elevated blood pressure and hypertension](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and/)
- [Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction](https://scholariq.org/papers/relation-between-renal-dysfunction-and-cardiovascular-outcomes-after-myocardial/)
- [A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction](https://scholariq.org/papers/a-clinical-trial-of-the-angiotensin-converting-enzyme-inhibitor-trandolapril-in/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.